Jennie Williams

发表

Establishment of three novel cell lines derived from African American patients with colorectal carcinoma: A unique tool for assessing racial health disparity

K. Shroyer, P. Ji, Joseph F LaComb, 2018, International journal of oncology.

NO-donating aspirin inhibits angiogenesis by suppressing VEGF expression in HT-29 human colon cancer mouse xenografts.

B. Rigas, N. Ouyang, Nengtai Ouyang, 2008, Carcinogenesis.

Growth inhibition of human colon cancer cells by nitric oxide (NO)-donating aspirin is associated with cyclooxygenase-2 induction and beta-catenin/T-cell factor signaling, nuclear factor-kappaB, and NO synthase 2 inhibition: implications for chemoprevention.

Jianjun Gao, L. Kopelovich, K. Kashfi, 2003, Cancer research.

NO-donating aspirin inhibits intestinal carcinogenesis in Min (APC(Min/+)) mice.

L. Kopelovich, K. Kashfi, B. Rigas, 2004, Biochemical and biophysical research communications.

NO-donating NSAIDs and cancer: an overview with a note on whether NO is required for their action.

B. Rigas, Jennie Williams, 2008, Nitric oxide : biology and chemistry.

Functional characterization of peroxisome proliferator‐activated receptor‐β/δ expression in colon cancer

J. Peters, F. Gonzalez, Bokai Zhu, 2011, Molecular carcinogenesis.

Phospho-valproic acid (MDC-1112) reduces pancreatic cancer growth in patient-derived tumor xenografts and KPC mice: enhanced efficacy when combined with gemcitabine.

B. Rigas, Joseph F LaComb, G. Mackenzie, 2019, Carcinogenesis.

Nitric oxide-donating aspirin induces G2/M phase cell cycle arrest in human cancer cells by regulating phase transition proteins.

Li Gao, Jennie Williams, 2012, International journal of oncology.

Nitric Oxide-Donating Nonsteroidal Anti-Inflammatory Drugs Inhibit the Growth of Various Cultured Human Cancer Cells: Evidence of a Tissue Type-Independent Effect

F. Traganos, K. Kashfi, B. Rigas, 2002, Journal of Pharmacology and Experimental Therapeutics.

Differential expression of miRNAs in colon cancer between African and Caucasian Americans: Implications for cancer racial health disparities

K. Shroyer, R. Bergamaschi, P. Ji, 2014, International journal of oncology.

C1q and C1q receptors (gC1qR and cC1qR) as potential novel targets for therapy against breast cancer

U. Kishore, E. Peerschke, Anuvinder Kaur, 2018 .

An in vitro study on the effect of synthesized tin(IV) complexes on glioblastoma, colorectal, and skin cancer cell lines

D. VanDerveer, P. Ji, Robert M. Johnson, 2016 .

Positional Isomerism Markedly Affects the Growth Inhibition of Colon Cancer Cells by Nitric Oxide-Donating Aspirin in Vitro and in Vivo

Francesca Benedini, Jianjun Gao, K. Kashfi, 2005, Journal of Pharmacology and Experimental Therapeutics.

Preliminary anti-cancer photodynamic therapeutic in vitro studies with mixed-metal binuclear ruthenium(II)-vanadium(IV) complexes.

F. Bai, P. Ji, G. Dismukes, 2013, Dalton transactions.

The Role of NSAIDs in the Prevention of Colon Cancer

B. Rigas, Jennie Williams, Y. Rayyan, 2002, Cancer investigation.

Nitric oxide-donating aspirin prevents pancreatic cancer in a hamster tumor model.

Jianjun Gao, L. Kopelovich, K. Kashfi, 2006, Cancer research.

Aberrant DNA Methylation: Implications in Racial Health Disparity

P. Ji, Ellen Li, Joseph F LaComb, 2016, PloS one.

Parallel comparison of Illumina RNA-Seq and Affymetrix microarray platforms on transcriptomic profiles generated from 5-aza-deoxy-cytidine treated HT-29 colon cancer cells and simulated datasets

Xiao Xu, Wei Zhu, Song Wu, 2013, BMC Bioinformatics.

A novel tricarbonylmethane agent (CMC2.24) reduces human pancreatic tumor growth in mice by targeting Ras

L. Golub, Joseph F LaComb, M. Nemesure, 2018, Molecular carcinogenesis.

Loss of the Krüppel-like factor 4 tumor suppressor is associated with epithelial-mesenchymal transition in colorectal cancer

K. Shroyer, Jessie Huang, V. Yang, 2019, bioRxiv.

NO-donating aspirin isomers downregulate peroxisome proliferator-activated receptor (PPAR)delta expression in APC(min/+) mice proportionally to their tumor inhibitory effect: Implications for the role of PPARdelta in carcinogenesis.

B. Rigas, N. Ouyang, Jennie Williams, 2006, Carcinogenesis.

A systematic review of genetic ancestry as a risk factor for incidence of non-small cell lung cancer in the US

B. Nemesure, Jennie Williams, Breanna A. James, 2023, Frontiers in Genetics.

The Effect of Race/Ethnicity on the Age of Colon Cancer Diagnosis.

K. Shroyer, R. Bergamaschi, Wei Zhu, 2013, Journal of health disparities research and practice.

IL-1β enhances cell viability and decreases 5-FU sensitivity in novel colon cancer cell lines derived from African American patients

L. Martello, J. Zabaleta, Jenny Paredes, 2022, Frontiers in Oncology.

P. Ji, J. Carethers, Xuefeng Wang, 2020, Frontiers in Oncology.

Protein nitration and nitrosylation by NO-donating aspirin in colon cancer cells: Relevance to its mechanism of action.

L. Kopelovich, P. Ji, B. Rigas, 2011, Experimental cell research.

NO-donating nonsteroidal antiinflammatory drugs (NSAIDs) inhibit colon cancer cell growth more potently than traditional NSAIDs: a general pharmacological property?

F. Traganos, K. Kashfi, B. Rigas, 2004, Biochemical pharmacology.

Abstract 3817: Nitric oxide-donating aspirin induces G2/M phase cell cycle arrest in human cancer cells by regulating phase transition proteins

Li Gao, Jennie Williams, 2012 .

NO-donating aspirin inhibits the activation of NF-kappaB in human cancer cell lines and Min mice.

Xiaoping Liu, P. Ji, B. Rigas, 2008, Carcinogenesis.

A novel NSAID derivative, phospho-ibuprofen, prevents AOM-induced colon cancer in rats

P. Ji, N. Ouyang, Jennie Williams, 2012, International journal of oncology.

NO-releasing NSAIDs and colon cancer chemoprevention: a promising novel approach (Review).

B. Rigas, Jennie Williams, 2002, International journal of oncology.

Regulation of peroxisome proliferator‐activated receptor‐β/δ by the APC/β‐CATENIN pathway and nonsteroidal antiinflammatory drugs

B. Rigas, J. Peters, M. Clapper, 2009, Molecular carcinogenesis.

Functional characterization of peroxisome proliferator‐activated receptor‐β/δ expression in colon cancer

F. Gonzalez, Bokai Zhu, Michael G. Borland, 2011, Molecular carcinogenesis.